Hi,
I did some checking about the date that Irrisept wound lavage obtained FDA clearance. It was on June 2021
https://www.prnewswire.com/news-releases/irrimax-receives-fda-clearance-for-irrisept-as-an-antimicrobial-wound-lavage-for-us-market-301314135.html
NXS obtained Xperience FDA clearance on about 26 April 2021
https://www.businesswire.com/news/home/20210427005875/en/Next-Science%E2%80%99s-XPERIENCE-No-Rinse-Antimicrobial-Solution-Cleared-by-FDA-for-Sale-in-USA
It is a fact that NXS obtained FDA clearance first. I think Irrimax cannot accept the fact that it "wasted" its resources on developing its irrisept wound lavage only to find out that NXS Xperience is a better product.
Ann: Irrimax complaint, page-20
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.015(10.0%) |
Mkt cap ! $39.44M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 13.5¢ | $119.9K | 836.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28579 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 24827 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NXS (ASX) Chart |